检索结果 - Sujith Sarvesh

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

    ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma 由 Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, Julienne L. Carstens, Jeremy B. Foote, Emily C. Graff, Yu-Hua Fang, Adam B. Keeton, Xi Chen, Jacob Valiyaveettil, Kristy Berry, Sejong Bae, Mehmet Akce, Greg Gorman, Karina J. Yoon, Upender Manne, M. R. Boyd, Donald J. Buchsbaum, Asfar S. Azmi, Yulia Y. Maxuitenko, Gary A. Piazza, Bassel F. El‐Rayes

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: